シェーグレン症候群患者に対するセビメリンの効果予測の検討 Efficacy prediction of cevimeline in patients with Sjogren's syndrome

この論文にアクセスする

この論文をさがす

著者

    • 中川 洋一 NAKAGAWA Yoichi
    • 鶴見大学歯学部口腔外科学第二講座 Second Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tsurumi University
    • 斎藤 一郎 SAITO Ichiro
    • 鶴見大学歯学部口腔病理学講座 Department of Pathology, School of Dental Medicine, Tsurumi University

抄録

The objective of this study was to examine clinical and immunological factors influencing the efficacy ofcevimeline hydrochloride hydrate (cevimeline) for the treatment of xerostomia in patients with Sjögren's syndrome (SS). Thirty patients with primary SS who received cevimeline were enrolled in this study. Whole stimulated sialometry (WSS) was performed before and after treatment (4 weeks after oral cevimeline was begun), and the increment rate of WSS was calculated. Multiple regression analysis was employed to examine the relative contributions of clinical and immunological factors, including age, pretreatment WSS, duration of disease, sialography, minor salivary gland biopsy, anti-Ro/SS-A antibodies, anti-La/SS-B antibodies, and antibodies to muscarinic type 3 receptors to the posttreatment results of WSS. Patients with normal sialographic findings, negative results of minor salivary gland biopsy, and absence of anti-La/SS-B antibodies had significantly higher increment rates of WSS than those with positive findings (p = 0.042, 0.002, and 0.018, respectively). The results of multiple regression analysis showed that sialography (coefficient =− 0.867, p = 0.004) and minor salivary gland biopsy (coefficient =− 0.869, p = 0.003) were significantly associated with the posttreatment WSS findings. Our preliminary results demonstrated a relation between the effect of cevimeline on saliva secretion and the degree of salivary gland destruction as evaluated by sialography and histopathological findings in the labial minor salivary glands. These diagnostic approaches could provide useful prognostic information on the efficacy of cevimeline in SS patients.

The objective of this study was to examine clinical and immunological factors influencing the efficacy ofcevimeline hydrochloride hydrate (cevimeline) for the treatment of xerostomia in patients with Sjögren's syndrome (SS). Thirty patients with primary SS who received cevimeline were enrolled in this study. Whole stimulated sialometry (WSS) was performed before and after treatment (4 weeks after oral cevimeline was begun), and the increment rate of WSS was calculated. Multiple regression analysis was employed to examine the relative contributions of clinical and immunological factors, including age, pretreatment WSS, duration of disease, sialography, minor salivary gland biopsy, anti-Ro/SS-A antibodies, anti-La/SS-B antibodies, and antibodies to muscarinic type 3 receptors to the posttreatment results of WSS. Patients with normal sialographic findings, negative results of minor salivary gland biopsy, and absence of anti-La/SS-B antibodies had significantly higher increment rates of WSS than those with positive findings (p = 0.042, 0.002, and 0.018, respectively). The results of multiple regression analysis showed that sialography (coefficient =− 0.867, p = 0.004) and minor salivary gland biopsy (coefficient =− 0.869, p = 0.003) were significantly associated with the posttreatment WSS findings. Our preliminary results demonstrated a relation between the effect of cevimeline on saliva secretion and the degree of salivary gland destruction as evaluated by sialography and histopathological findings in the labial minor salivary glands. These diagnostic approaches could provide useful prognostic information on the efficacy of cevimeline in SS patients.

収録刊行物

  • 日本口腔外科学会雑誌

    日本口腔外科学会雑誌 57(5), 242-250, 2011-05-20

    社団法人 日本口腔外科学会

参考文献:  22件中 1-22件 を表示

各種コード

  • NII論文ID(NAID)
    10030271858
  • NII書誌ID(NCID)
    AN00189163
  • 本文言語コード
    JPN
  • 資料種別
    ART
  • ISSN
    00215163
  • NDL 記事登録ID
    11131738
  • NDL 雑誌分類
    ZS44(科学技術--医学--歯科学・口腔外科学)
  • NDL 請求記号
    Z19-145
  • データ提供元
    CJP書誌  NDL  J-STAGE 
ページトップへ